Diferencia entre revisiones de «Neuromuscular blocking agents»

Línea 25: Línea 25:
|[[Atracurium]] (Tracrium)
|[[Atracurium]] (Tracrium)
|90
|90
|30 min or less<ref name=Rang151/>
|30 min or less
|
|
*[[hypotension]], transiently,<ref name=Rang151/> by release of histamine
*Transient [[hypotension]]
*Toxic metabolite called [[laudanosine]], greater accumulation in individuals with renal failure
*Toxic metabolite (laudanosine), greater accumulation in individuals with renal failure
|-
|-
|[[Vecuronium]] (Norcuron)
|[[Vecuronium]] (Norcuron)
Línea 39: Línea 39:
|45–70
|45–70
|may promote muscarinic block
|may promote muscarinic block
|
|-
|-
|[[Pancuronium]] (Pavulon)
|[[Pancuronium]] (Pavulon)

Revisión del 03:34 24 feb 2015

Background

  • Non-depolarizing
    • Competitively block binding of ACh to its receptors
  • Depolarizing
    • Depolarizing skeletal muscle fiber
    • Persistent depolarization makes the muscle fiber resistant to further stimulation by ACh

Types

Neuromuscular Blocking Agents
Agent Time to onset (seconds) Duration (minutes) Side effects
Non-Depolarizing
Succinylcholine fasciculations, post-operative pain
Depolarizing
Atracurium (Tracrium) 90 30 min or less
  • Transient hypotension
  • Toxic metabolite (laudanosine), greater accumulation in individuals with renal failure
Vecuronium (Norcuron) 60 30–40 Few, may cause prolonged paralysis and promote muscarinic block
Rocuronium (Zemuron) 75 45–70 may promote muscarinic block
Pancuronium (Pavulon) 90 180 or more

Sources